Studies have shown that overexpressing GLS1 enhances the proliferation of HCC cells, which involves the AKT/GSK3 β/cyclin D1 axis [104], while the identity of CSCs is regulated by GLS1 via the ROS/WNT/β-catenin pathway [71]. The gene discussed is CCND1; the disease is hepatocellular carcinoma.